Toulouse and Archamps, France (ots/PRNewswire) - Dr. Philippe Lluel from Urosphere, a company specialized in preclinical pharmacology of urogenital tract, presented on behalf of all investigators two scientific posters at the prestigious congress of the European Association of Urology (EAU) in London, showing for ...
Bagsværd, Denmark (ots/PRNewswire) - Canada first country to launch Fiasp® This material is intended for global medical media only. For journalistic assessment and preparation before publication. Today, Novo Nordisk announced that Fiasp®, a new, fast-acting mealtime insulin for the treatment of diabetes in ...
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for UK-based media - Only FDA-approved treatment for metastatic Merkel cell carcinoma, a rare and aggressive skin cancer - First indication for BAVENCIO, a human anti-PD-L1 antibody Merck and Pfizer Inc. (NYSE: PFE) today announced that the US Food and ...
Brussels (ots/PRNewswire) - During the "Nudging for Good" Awards Ceremony presented in Brussels, My UV Patch, La Roche-Posay's digital breakthrough innovation to change bad sun habits into life-saving ones, was awarded the Diamond Award by the European Brands Association (AIM). Launched in 2016, the "Nudging for Good" Award aims to honor brands that make it easy and ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - CINRYZE is now the first and only Hereditary angioedema treatment approved for routine prevention in paediatrics Shire plc (LSE: SHP, NASDAQ: SHPG) announced that the European Commission (EC) has approved a label extension granting three new indications for CINRYZE® (C1 inhibitor ...
European Hematology Association (EHA)
Vilnius, Lithuania (ots/PRNewswire) - Patients suffering from rare blood disorders will benefit from networks of excellence across the European Member States. At the third conference on European Reference Networks (ERNs) yesterday in Vilnius, Lithuania, EuroBloodNet was officially awarded as one of the recently approved ERNs. ERNs is an initiative of the European ...
Lestrem, France (ots/PRNewswire) - Reinforces position as a supplier of excipients and raw materials for the pharmaceutical and biopharmaceutical industries Roquette, a global leader in innovative plant-based pharmaceutical ingredients, announces its commitment to provide new product offerings to address the growing demand for excipients and raw materials for the biopharmaceutical market. (Logo: ...
Darmstadt, Germany (ots/PRNewswire) - - Merck integrates innovative Eeva® Test with Geri(TM) incubation platform, bringing individualized incubation and outcome prediction together - Geri(TM) humidity technology aims to further advance incubation to precisely monitor and manage the humidity level in the incubator Merck, a leading science and technology company, today ...
Kaiseraugst, Switzerland (ots/PRNewswire) - - Breakthrough for animal nutrition to reduce impact on ocean resources and making it more sustainable - Commercial-scale facility for algal oil for salmon aquaculture and pet food to be built in the United States - Further develop and produce a high value algal oil with a ...
Lausanne (ots) - Change in name reflects new strategy to invest in smart data, therapeutics and diagnostics Debiopharm Diagnostics SA, the strategic investment fund of Debiopharm Group(TM) (www.debiopharm.com), announced its new strategy and the change of name to Debiopharm Innovation Fund SA effective today. With the aim of speeding up innovations that radically ...
Milan (ots/PRNewswire) - GfK's sales tracking of four key European retail optics markets (Italy, France, Spain and Germany), shows a turnover of EUR17.6 billion for total year 2016. This is a sales value growth of 0.9 percent compared to the previous year. GfK released the findings at the international MIDO 2017 trade fair in Milan. GfK tracks sales data in the optician channel for sunglasses, frames, spectacle lenses, ...
Ballerup, Denmark and Orlando, Florida (ots/PRNewswire) - LEO Pharma today announced positive results from a Phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with moderate to severe atopic dermatitis (AD), a serious and chronic form of eczema. Tralokinumab is an investigational ...
Sunnyvale, California (ots/PRNewswire) - The Internet is one of the first places patients turn to for healthcare information after receiving a cancer diagnosis, according to the American Cancer Society. Accuray Incorporated (NASDAQ: ARAY) is launching http://www.cyberknife.com and http://www.tomotherapy.com to provide an additional resource for cancer patients to turn to for information about their disease and potential ...
Amsterdam and Vienna (ots/PRNewswire) - - iDose[4] proprietary reconstruction technique lowers operating costs by increasing tube life - iFlow intelligent workflow platform enables consistent image quality from operator-to-operator to reduce rescans Royal Philips (http://www.philips.com/) (NYSE: PHG; AEX: PHIA) ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK- or US-based media - More patients now able to receive a standard-of-care treatment with Erbitux plus FOLFIRI or FOLFOX - NICE's recommendation is a significant step forward in Merck's aspiration to ensure cancer patients have optimal access to effective ...
Amsterdam and Vienna (ots/PRNewswire) - Royal Philips (http://www.usa.philips.com/) (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled new advanced radiology solutions at the 2017 European Congress of Radiology (https://www.myesr.org/ecr-2017) (ECR), beginning March 1 at the Austria Center ...
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US and UK-based media - Second Biologics License Application accepted by the FDA for avelumab - Prognosis for urothelial carcinoma is currently poor, particularly when the disease has metastasized Merck and Pfizer Inc. today announced that the US ...
Hørsholm, Denmark (ots/PRNewswire) - ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF) today announced that for the first time, allergy immunotherapy is now recommended as a treatment option in the Global Initiative for Asthma (GINA) report: Global Strategy for Asthma Management and Prevention. This global strategy is a ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for U.S. and UK based media - Ready-to-use pre-filled pen provides a convenient treatment option for patients - Simplified injection device for self-administration comes in multiple doses, addressing individual needs of patients Merck, a leading science and technology company, today announced that the European ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - This Press Release is intended for Global Use If approved, Natpar would be the first licensed recombinant parathyroid hormone in Europe for the management of chronic hypoparathyroidism, the only endocrine-deficiency disorder with no hormone treatment[1] Shire plc (LSE: SHP, ...
Berlin (ots/PRNewswire) - Tillotts Pharma is strengthening its presence in the German market: the Berlin office was opened in January 2017 under the management of Magdalena Kritikos. The portfolio includes Entocort® for the treatment of Crohn's disease, Asacol® for the treatment of ulcerative colitis, and VistaPrep® for bowel preparation before endoscopy. With ...
Amsterdam (ots/PRNewswire) - - Developed in collaboration with leading hospitals worldwide, Philips Azurion (https://www.usa.philips.com/healthcare/resources/landing/azurion) is an innovative image-guided therapy platform that allows clinicians to easily and confidently perform a wide range of routine and complex ...
Seattle (ots/PRNewswire) - - First Detailed Results from SWORD Clinical Trial Program Show Investigational Two-drug Combination as Effective as Three- or Four-drug Regimens as Maintenance Therapy in Patients who have Already Achieved Viral Suppression Janssen Sciences Ireland UC (Janssen) announced positive results ...
Darmstadt, Germany (ots/PRNewswire) - - Post hoc analysis of Phase III CLARITY study data recently published in Multiple Sclerosis Journal showed statistically significant reduction in brain atrophy in patients on a short course of investigational Cladribine Tablets over two years compared with patients receiving placebo - These findings correlated with effects on ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - Shire presentations at EAHAD 2017 underscore the company's leadership in improving global standards of care Shire plc (LSE: SHP, NASDAQ: SHPG), the leading biotechnology company focused on serving individuals with rare diseases, presented its new estimate of the Global Annual Bleed Rate (GABR), an effort to build on current global ...
Paris (ots/PRNewswire) - This material is intended for global medical media only. For journalistic assessment and preparation before publication. Poster #P024 Patient preference data presented today at the 10th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) demonstrated the ...
Paris (ots/PRNewswire) - Water needs is a common ground across populations and cultures according to the survey but local habits and knowledge still affect water consumption Kantar TNS and Nestle Waters published a survey on attitudes about water consumption in seven countries: China, France, Italy, Mexico, the UK, the US and Turkey. To view the Multimedia News Release, please click: ...
Wevelgem, Belgium (ots/PRNewswire) - Jacoti Hearing Suite, an innovative set of hearing applications created by Jacoti bvba, has been named a Global Mobile Awards 2017 Nominee. Products entered in this prestigious program are judged by a preeminent panel of more than 250 independent judges from across the world, ...
Dublin (ots/PRNewswire) - -- Allergan enters skin quality category with new injectable product using VYCROSS® technology[1] for use on the face, neck, décolletage and hands[2] -- Hyaluronic Acid (HA) gel designed to improve skin's smoothness (absence of fine lines), hydration and elasticity for up to nine months ...
Calgary, Alberta (ots/PRNewswire) - Several Key Proteins That Drive Kidney (Renal) Disease and Dialysis Risk are Downregulated After a Single Dose of Apabetalone Resverlogix Corp. ("Resverlogix" or the "Company") (TSX: RVX) today announced preliminary results from the New Zealand based Phase 1 trial with severe kidney (renal) impaired patients. The data showed ...